文献速递瓣膜外科

经导管主动脉瓣置换术住院费用的中心层面差异

Center-Level Variation in Hospitalization Costs of Transcatheter Aortic Valve Replacement.
PubMed 文献 · Ann Thorac Surg · 2023-03-20

基于2016至2018年全国再入院数据库,纳入约119492例择期孤立经导管主动脉瓣置换术成人患者,采用多水平混合效应模型分析住院费用。结果显示54.3%的费用变异归因于医院间差异而非患者因素,高费用医院状态与年手术量和死亡率、急性肾损伤、呼吸衰竭、神经系统并发症的比值比均无显著关联。

要点

  • 约119492例择期孤立经导管主动脉瓣置换术患者中,54.3%的费用变异归因于医院间差异。
  • 各医院基线费用从-26000美元到162000美元不等。
  • 高费用医院状态与年经导管主动脉瓣置换术手术量及死亡率、急性肾损伤、呼吸衰竭、神经系统并发症的比值比均无显著关联。

核心结论

  • 经导管主动脉瓣置换术费用存在显著变异,且大部分归因于中心层面而非患者因素。
  • 医院经导管主动脉瓣置换术手术量和并发症发生并非观察到的费用变异的驱动因素。

研究设计与样本

  • 基于2016至2018年全国再入院数据库的回顾性分析,纳入所有接受择期孤立经导管主动脉瓣置换术的成人患者。
  • 采用多水平混合效应模型识别与住院费用相关的患者和医院特征,并生成各医院的随机截距作为该中心归因的基线费用。
  • 基线费用最高十分位的医院被归类为高费用医院,随后评估高费用医院状态与院内死亡率和围术期并发症的关联。

主要发现

  • 估计119492例患者符合研究标准,平均年龄80岁,女性性别患病率45.9%。
  • 随机截距分析表明,54.3%的费用变异归因于医院间差异而非患者因素。
  • 围术期呼吸衰竭、神经系统并发症和急性肾损伤与发作期支出增加相关,但并未解释观察到的中心层面变异。
  • 各医院相关的基线费用范围为-26000美元至162000美元。
  • 高费用医院状态与年经导管主动脉瓣置换术手术量或死亡率(P = .83)、急性肾损伤(P = .18)、呼吸衰竭(P = .32)或神经系统并发症(P = .55)的比值比无关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Using a nationally representative database, the present study evaluated the degree of center-level variation in the cost of transcatheter aortic valve replacement (TAVR). METHODS: All adults undergoing elective, isolated TAVR were identified in the 2016 to 2018 Nationwide Readmissions Database. Multilevel mixed-effects models were used to identify patient and hospital characteristics associated with hospitalization costs. The random intercept for each hospital was generated and considered to be the baseline cost attributable to care at each center. Hospitals in the highest decile of baseline costs were classified as high-cost hospitals. The association of high-cost hospital status with in-hospital mortality and perioperative complications was subsequently assessed. RESULTS: An estimated 119,492 patients, with a mean age of 80 years and a 45.9% prevalence of female sex, met the study criteria. Analysis of random intercepts indicated that 54.3% of variability in costs was attributable to interhospital differences rather than patient factors. Perioperative respiratory failure, neurologic complications, and acute kidney injury were associated with increased episodic expenditure but did not explain the observed center-level variation. The baseline cost associated with each hospital ranged from -$26,000 to $162,000. Notably, high-cost hospital status was not linked to annual TAVR caseload or to odds of mortality (P = .83), acute kidney injury (P = .18), respiratory failure (P = .32), or neurologic complications (P = .55). CONCLUSIONS: The present analysis identified significant variation in the cost of TAVR, which was largely attributable to center-level rather than patient factors. Hospital TAVR volume and occurrence of complications were not drivers of the observed variation.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Sanaiha Y, Verma A, Downey P, et al. Center-Level Variation in Hospitalization Costs of Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2023. PMID: 36940900. doi:10.1016/j.athoracsur.2023.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。